Medifast
MED
284 hedge funds and large institutions have $1.75B invested in Medifast in 2022 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 105 increasing their positions, 94 reducing their positions, and 33 closing their positions.
12% more repeat investments, than reductions
Existing positions increased: 105 | Existing positions reduced: 94
3% more capital invested
Capital invested by funds: $1.7B → $1.75B (+$51.4M)
3% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 33
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
1% less funds holding
Funds holding: 288 → 284 (-4)
1.88% less ownership
Funds ownership: 86.03% → 84.15% (-1.9%)
17% less call options, than puts
Call options by funds: $10.1M | Put options by funds: $12.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
American Century Companies
Kansas City,
Missouri
|
+$19.1M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$15.9M |
| 3 |
Morgan Stanley
New York
|
+$13.7M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$10.3M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$8.75M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCPM
Cooper Creek Partners Management
New York
|
-$25.6M |
| 2 |
BlackRock
New York
|
-$21.8M |
| 3 |
CCM
Candlestick Capital Management
Greenwich,
Connecticut
|
-$13.2M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$7.96M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$6.54M |
MED Hedge Fund Activity: Q2 2022 in Review
284 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q2 2022, worth a combined $1.75B — up 3% from $1.7B a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new MED positions and 33 closed out — a net gain of 1 holder — while 105 added to existing stakes and 94 trimmed.
The largest buyer was American Century Companies, adding an estimated $19.1M. The largest seller was Cooper Creek Partners Management, exiting entirely with an estimated $25.6M sold.
- 284 institutional investors held Medifast (MED) as of Q2 2022, down from 288 in Q1 2022.
- Funds reported $1.75B of Medifast stock for Q2 2022, up 3% quarter-over-quarter.
- 34 funds opened new Medifast positions in Q2 2022 and 33 closed out, a net change of +1 holder.
- The largest Medifast buyer in Q2 2022 was American Century Companies, an estimated $19.1M added.
- The largest Medifast seller in Q2 2022 was Cooper Creek Partners Management, an estimated $25.6M sold.
Based on aggregated 13F filings for Q2 2022.